Rana Abdelnabi

Leuven, VLG 3001, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

A High-Throughput Antiviral Assay Based on a Sindbis Virus-GFP for the Discovery of Inhibitors of Alphavirus Replication.

A High-Throughput Antiviral Assay Based on a Sindbis Virus-GFP for the Discovery of Inhibitors of Alphavirus Replication.

Journal: Viruses

Published: February 05, 2026

1'-Cyanocytidine-5'-isobutyryl is a potent SARS-CoV-2 inhibitor in culture and infected Syrian hamsters.

1'-Cyanocytidine-5'-isobutyryl is a potent SARS-CoV-2 inhibitor in culture and infected Syrian hamsters.

Journal: Science advances

Published: October 03, 2025

Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro Inhibitor.

Discovery and Preclinical Profile of ALG-097558, a Pan-Coronavirus 3CLpro Inhibitor.

Journal: Journal of medicinal chemistry

Published: June 30, 2025

The multifaceted role of the viral 2A protease in enterovirus replication and antagonism of host antiviral responses.

The multifaceted role of the viral 2A protease in enterovirus replication and antagonism of host antiviral responses.

Journal: PLoS pathogens

Published: March 23, 2025

Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo.

Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo.

Journal: Antiviral research

Published: March 21, 2025

Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo.

Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo.

Journal: bioRxiv : the preprint server for biology

Published: February 03, 2025

Functional Humoral Response During Intranasal Convalescent Plasma Prophylaxis for Severe Acute Respiratory Syndrome Coronavirus 2.

Functional Humoral Response During Intranasal Convalescent Plasma Prophylaxis for Severe Acute Respiratory Syndrome Coronavirus 2.

Journal: The Journal of infectious diseases

Published: January 24, 2025

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base.

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base.

Journal: Nature communications

Published: August 16, 2024

The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model.

The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model.

Journal: Antiviral research

Published: June 12, 2024

The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model.

The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model.

Journal: bioRxiv : the preprint server for biology

Published: May 27, 2024

A coronavirus assembly inhibitor that targets the viral membrane protein.

A coronavirus assembly inhibitor that targets the viral membrane protein.

Journal: Nature

Published: April 06, 2024

A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein.

A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein.

Journal: Nature

Published: February 21, 2024

Showing 1-12 of 79

Last Updated: 09/26/2026